Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Gastric Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    June 2025
  1. GEERTS JFM, Vissers PAJ, Mostert B, Wijnhoven BPL, et al
    Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.
    Int J Cancer. 2025 Jun 5. doi: 10.1002/ijc.35491.
    PubMed     Abstract available


  2. CHAN WC, Millwood I, Kartsonaki C, Du H, et al
    Adiposity and risks of gastrointestinal cancers: A 10-year prospective study of 0.5 million Chinese adults.
    Int J Cancer. 2025;156:2094-2106.
    PubMed     Abstract available


    May 2025
  3. PELC Z, Sedlak K, Mlak R, Endo Y, et al
    Impact of prognostic nutritional index on oncological outcomes and mortality among advanced gastric cancer patients: European GASTRODATA registry analysis.
    Int J Cancer. 2025 May 28. doi: 10.1002/ijc.35489.
    PubMed     Abstract available


    March 2025
  4. JIANG XW, Zhang L, Liu ZC, Zhou T, et al
    Integrative metabolomics and microbiomics analysis reveals distinctive microbiota-metabolites interactions in gastric carcinogenesis.
    Int J Cancer. 2025 Mar 10. doi: 10.1002/ijc.35392.
    PubMed     Abstract available


  5. ENGLISH KA, Goldsworthy M, Willis B, Kooblall KG, et al
    Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanisms.
    Int J Cancer. 2025;156:980-992.
    PubMed     Abstract available


    January 2025
  6. SLOTMAN E, Pape M, van Laarhoven HWM, Pouw RE, et al
    Considerations to forgo systemic treatment in patients with advanced esophageal or gastric cancer: A real-world evidence study.
    Int J Cancer. 2025 Jan 9. doi: 10.1002/ijc.35314.
    PubMed     Abstract available


    December 2024
  7. SEWASTJANOW-SILVA M, Kwiatkowski E, Yamashita K, Abdelhakeem A, et al
    Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.
    Int J Cancer. 2024;155:2277-2286.
    PubMed     Abstract available


  8. INOUE-CHOI M, Freedman ND, Etemadi A, Hashemian M, et al
    One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study.
    Int J Cancer. 2024;155:1944-1957.
    PubMed     Abstract available


    October 2024
  9. YAN X, Zeng H, Li H, Cao M, et al
    The current infection with Helicobacter pylori and association with upper gastrointestinal lesions and risk of upper gastrointestinal cancer: Insights from multicenter population-based cohort study.
    Int J Cancer. 2024;155:1203-1211.
    PubMed     Abstract available


    August 2024
  10. LIU J, Gan T, Hu W, Li Y, et al
    Does ambient particulate matter 1 increase the risk of gastric cancer in the northwest of China?
    Int J Cancer. 2024 Aug 23. doi: 10.1002/ijc.35144.
    PubMed     Abstract available


    July 2024
  11. WANG R, Chen XZ
    Comment on "Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study".
    Int J Cancer. 2024;155:184-185.
    PubMed    


    June 2024
  12. MASETTI M, Al-Batran SE, Goetze TO, Thuss-Patience P, et al
    Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
    Int J Cancer. 2024;154:2142-2150.
    PubMed     Abstract available


  13. NAGEL G, Chen J, Jaensch A, Skodda L, et al
    Long-term exposure to air pollution and incidence of gastric and the upper aerodigestive tract cancers in a pooled European cohort: The ELAPSE project.
    Int J Cancer. 2024;154:1900-1910.
    PubMed     Abstract available


    May 2024
  14. GONZALEZ-PALACIOS S, Compan-Gabucio LM, Torres-Collado L, Oncina-Canovas A, et al
    The protective effect of dietary folate intake on gastric cancer is modified by alcohol consumption: A pooled analysis of the StoP Consortium.
    Int J Cancer. 2024 May 16. doi: 10.1002/ijc.35004.
    PubMed     Abstract available


    December 2023
  15. SASAHARA M, Kanda M, Tanaka C, Shimizu D, et al
    Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis.
    Int J Cancer. 2023 Dec 27. doi: 10.1002/ijc.34831.
    PubMed     Abstract available


  16. ZHANG Q, Zhou Y, Song L, Fang W, et al
    China special issue on gastrointestinal tumors-Improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study.
    Int J Cancer. 2023;153:1885-1893.
    PubMed     Abstract available


    November 2023
  17. GOETZE TO, Stein A, Lorenzen S, Habibzada T, et al
    Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy.
    Int J Cancer. 2023;153:1726-1733.
    PubMed     Abstract available


  18. RIJKEN A, Pape M, Simkens GA, de Hingh IHJT, et al
    Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
    Int J Cancer. 2023 Nov 2. doi: 10.1002/ijc.34780.
    PubMed     Abstract available


    October 2023
  19. FAN XH, Zhang Y, Wang P, Song QQ, et al
    A noninvasive multianalytical approach establishment for risk assessment and gastric cancer screening.
    Int J Cancer. 2023 Oct 16. doi: 10.1002/ijc.34739.
    PubMed     Abstract available


    September 2023
  20. LLACH J, Salces I, Guerra A, Penas B, et al
    Endoscopic surveillance for familial intestinal gastric cancer in low-incidence areas: An effective strategy.
    Int J Cancer. 2023 Sep 7. doi: 10.1002/ijc.34714.
    PubMed     Abstract available


  21. PALOMAR-CROS A, Straif K, Romaguera D, Aragones N, et al
    Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain).
    Int J Cancer. 2023;153:979-993.
    PubMed     Abstract available


    August 2023
  22. CHENG L, Chang Y, Xia Z, Liu Y, et al
    Remote modulation of WWOX by an intronic variant associated with survival of Chinese gastric cancer patients.
    Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34703.
    PubMed     Abstract available


  23. CAO F, Sun H, Yang Z, Bai Y, et al
    Multiple approaches revealed MGc80-3 as a somatic hybrid with HeLa cells rather than a gastric cancer cell line.
    Int J Cancer. 2023 Aug 6. doi: 10.1002/ijc.34677.
    PubMed     Abstract available


    July 2023
  24. GOETZE TO, Hofheinz RD, Gaiser T, Schmalenberg H, et al
    Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
    Int J Cancer. 2023;153:153-163.
    PubMed     Abstract available


    March 2023
  25. GHASEMI-KEBRIA F, Semnani S, Fazel A, Etemadi A, et al
    Esophageal and gastric cancer incidence trends in Golestan, Iran: an age-period-cohort analysis 2004-2018.
    Int J Cancer. 2023 Mar 21. doi: 10.1002/ijc.34518.
    PubMed     Abstract available


  26. MOHRING C, Manczak A, Timotheou A, Sadeghlar F, et al
    Perioperative Therapy with Flot4 Significantly Increases Survival in Patients with Gastroesophageal and Gastric Cancer in A Large Real-World Cohort.
    Int J Cancer. 2023 Mar 15. doi: 10.1002/ijc.34511.
    PubMed     Abstract available


  27. KUIJPER SC, Pape M, Vissers PAJ, Jeene PM, et al
    Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Mar 1. doi: 10.1002/ijc.34488.
    PubMed     Abstract available


    February 2023
  28. PAPE M, Kuijper SC, Vissers PAJ, Ruurda JP, et al
    Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Feb 25. doi: 10.1002/ijc.34480.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.